MedTrace Logo

Furosemide Alone or Unexpectedly With Solution of Hypertonic Saline in Nephrotic Syndrome

NCT03750136 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-11-23

No results posted yet for this study

Summary

The trial will test the hypothesis that hypertonic saline on top of standard diuretic treatment will help achieve adequate diuresis in patients with nephrotic syndrome.

Conditions

  • Nephrotic Syndrome

Interventions

DRUG

Hypertonic saline

high dose furosemide with hypertonic saline 3x daily

DRUG

Furosemide Injection

high dose furosemide

Sponsors & Collaborators

  • Medical University of Bialystok

    lead OTHER

Principal Investigators

  • Alicja Rydzewska-Rosolowska, MD · Medical University of Białystok

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-15
Primary Completion
2023-01-01
Completion
2023-03-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03750136 on ClinicalTrials.gov